Similar articles for PMID: 27765855

Year	Number of Results
1887	1
1956	1
2003	2
2005	4
2006	4
2007	1
2008	1
2009	2
2010	5
2011	5
2012	5
2013	14
2014	9
2015	12
2016	18
2017	33
2018	27
2019	21
2020	15
2021	10
2022	9
2023	4
2024	0

1

Molecular Drug Imaging: ⁸⁹Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.

Jansen MH, Veldhuijzen van Zanten SEM, van Vuurden DG, Huisman MC, Vugts DJ, Hoekstra OS, van Dongen GA, Kaspers GL. Jansen MH, et al. J Nucl Med. 2017 May;58(5):711-716. doi: 10.2967/jnumed.116.180216. Epub 2016 Oct 20. J Nucl Med. 2017. PMID: 27765855 Free article. Clinical Trial.

2

Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models.

Jansen MH, Lagerweij T, Sewing AC, Vugts DJ, van Vuurden DG, Molthoff CF, Caretti V, Veringa SJ, Petersen N, Carcaboso AM, Noske DP, Vandertop WP, Wesseling P, van Dongen GA, Kaspers GJ, Hulleman E. Jansen MH, et al. Mol Cancer Ther. 2016 Sep;15(9):2166-74. doi: 10.1158/1535-7163.MCT-15-0558. Epub 2016 Jun 20. Mol Cancer Ther. 2016. PMID: 27325687

3

89Zr-bevacizumab PET imaging in primary breast cancer.

Gaykema SB, Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, Timmer-Bosscha H, Pot L, van Dam GM, van der Meulen SB, de Jong JR, Bart J, de Vries J, Jansen L, de Vries EG, Schröder CP. Gaykema SB, et al. J Nucl Med. 2013 Jul;54(7):1014-8. doi: 10.2967/jnumed.112.117218. Epub 2013 May 7. J Nucl Med. 2013. PMID: 23651946 Free article. Clinical Trial.

4

Multiregional Tumor Drug-Uptake Imaging by PET and Microvascular Morphology in End-Stage Diffuse Intrinsic Pontine Glioma.

Veldhuijzen van Zanten SEM, Sewing ACP, van Lingen A, Hoekstra OS, Wesseling P, Meel MH, van Vuurden DG, Kaspers GJL, Hulleman E, Bugiani M. Veldhuijzen van Zanten SEM, et al. J Nucl Med. 2018 Apr;59(4):612-615. doi: 10.2967/jnumed.117.197897. Epub 2017 Aug 17. J Nucl Med. 2018. PMID: 28818988 Free article.

5

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.

den Hollander MW, Bensch F, Glaudemans AW, Oude Munnink TH, Enting RH, den Dunnen WF, Heesters MA, Kruyt FA, Lub-de Hooge MN, Cees de Groot J, Pearlberg J, Gietema JA, de Vries EG, Walenkamp AM. den Hollander MW, et al. J Nucl Med. 2015 Sep;56(9):1310-4. doi: 10.2967/jnumed.115.154401. Epub 2015 Jul 1. J Nucl Med. 2015. PMID: 26135113 Free article. Clinical Trial.

6

89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

Oosting SF, van Asselt SJ, Brouwers AH, Bongaerts AH, Steinberg JD, de Jong JR, Lub-de Hooge MN, van der Horst-Schrivers AN, Walenkamp AM, Hoving EW, Sluiter WJ, Zonnenberg BA, de Vries EG, Links TP. Oosting SF, et al. J Nucl Med. 2016 Aug;57(8):1244-50. doi: 10.2967/jnumed.115.167643. Epub 2016 May 12. J Nucl Med. 2016. PMID: 27173161 Free article.

7

89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.

Menke-van der Houven van Oordt CW, Gootjes EC, Huisman MC, Vugts DJ, Roth C, Luik AM, Mulder ER, Schuit RC, Boellaard R, Hoekstra OS, van Dongen GA, Verheul HM. Menke-van der Houven van Oordt CW, et al. Oncotarget. 2015 Oct 6;6(30):30384-93. doi: 10.18632/oncotarget.4672. Oncotarget. 2015. PMID: 26309164 Free PMC article. Clinical Trial.

8

Evaluation of ¹¹C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma.

Tinkle CL, Duncan EC, Doubrovin M, Han Y, Li Y, Kim H, Broniscer A, Snyder SE, Merchant TE, Shulkin BL. Tinkle CL, et al. J Nucl Med. 2019 Mar;60(3):312-319. doi: 10.2967/jnumed.118.212514. Epub 2018 Aug 2. J Nucl Med. 2019. PMID: 30072503 Free PMC article.

9

Correlation of ¹⁸F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.

Zukotynski KA, Vajapeyam S, Fahey FH, Kocak M, Brown D, Ricci KI, Onar-Thomas A, Fouladi M, Poussaint TY. Zukotynski KA, et al. J Nucl Med. 2017 Aug;58(8):1264-1269. doi: 10.2967/jnumed.116.185389. Epub 2017 Mar 30. J Nucl Med. 2017. PMID: 28360212 Free PMC article.

10

Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.

Meyer JP, Edwards KJ, Kozlowski P, Backer MV, Backer JM, Lewis JS. Meyer JP, et al. J Nucl Med. 2016 Nov;57(11):1811-1816. doi: 10.2967/jnumed.116.173237. Epub 2016 Jul 7. J Nucl Med. 2016. PMID: 27390161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

182 results

Results by year